1. Background {#sec1}
=============

Vascular endothelial dysfunction contributes to the development of both macrovascular and microvascular complications in type 1 diabetes (T1D) and there is considerable evidence that patients with T1D have increased endothelial stress/injury and reduced endothelial repair. Recent studies have indicated that adolescents with T1D have impaired flow mediated vasodilation, as measured using either brachial artery ultrasound or venous occlusion plethysmography \[[@B1]--[@B6]\]. Flow mediated vasodilation is due to endothelial nitric oxide release and thus is an effective measure of endothelial function.

Beyond this, there is good evidence of impaired endothelial repair capacity in T1D. Studies in mice indicate that animals with streptozotocin-induced diabetes have impaired vascular repair following hindlimb ischemia \[[@B7]\]. Similarly, vascular repair is impaired in control animals following transplantation of bone marrow derived stem cells from diabetic animals compared to those receiving cells from healthy animals \[[@B8]\]. Both studies indicated that progenitor cell counts were reduced in diabetic animals. Studies in humans have generally indicated reduced progenitors cell counts in young adults with T1D without overt complications \[[@B9]--[@B11]\]. Interestingly, in T1D adolescents, Dimeglio et al. \[[@B12]\] found decreased CD 34+CD133+CD31+ or circulating endothelial progenitor cells (CPCs), as reported in adults, but increased CD34+ CD45− cells or endothelial colony forming cells (ECFCs). They also found a negative relationship between the ECFCs and CPCs. They believed that the decreased CPCs indicated reduced repair capacity and the increased ECFCs were due to increased recruitment due to ongoing endothelial damage. The former conclusion was confirmed by a positive relationship between CPCs and endothelial function as measured using skin blood flow response to acetylcholine iontophoresis. Importantly, they found no relationships between any measure of glucose control and either CPCs or ECFCs.

Hyperglycemia-induced oxidative stress plays a key pathophysiological role in damaging endothelial function in diabetes \[[@B13], [@B14]\]. Acute hyperglycemia, also, profoundly increases muscle blood flow probably through osmotic effects in both healthy adults \[[@B15]\] and adolescents with T1D \[[@B16]\]. This pronounced increase in blood flow leads to a diminished incremental response to flow mediated vasodilation, possibly through a ceiling effect. A direct adverse effect of glucose variability on endothelial cells has, also, been demonstrated. Protein kinase-c levels, apoptotic rates, and biochemical markers of endothelial cell dysfunction are higher in endothelial cells exposed to intermittent glycemic levels of 90 or 360 mg/dL than in cells exposed continuously to either 90 or 360 mg/dL \[[@B17]\]. It is thought that the glucose fluctuations prevent the cells from adapting to the hyperglycemic condition. The adverse effect of oscillating glucose levels has been confirmed in adults with and without type 2 diabetes. Oscillating hyperglycemic and euglycemic clamp over 24 hours leads to greater impairment in endothelial function (measured using flow mediated vasodilation) and greater oxidative damage via reactive nitrogen species than does constant hyperglycemia \[[@B18]\].

Because of the above data, the primary goals of this study were to determine the effects of various measures of glycemia on endothelial function and endothelial repair capacity in adolescents with T1D. Specific measures that were studied include fasting glucose, 3 day average glucose and glucose standard deviation as determined via continuous glucose monitoring, hemoglobin A1c, and hemoglobin A1c area under the curve since diagnosis of diabetes (HbA1cAUC). Increasing our understanding how glucose control affects endothelial function and repair in adolescents will enhance our knowledge of the early pathophysiology of cardiovascular disease in T1D.

2. Methods {#sec2}
==========

2.1. Subjects {#sec2.1}
-------------

17 adolescents (8 females, 9 males) with type 1 DM were recruited from the Pediatric Diabetes Clinic of Nationwide Children\'s Hospital (NCH). Their mean age was 13.1 ± 1.6 years (mean ± SD) and their mean body mass index was 20.3 ± 3.1 kg/m^2^. Mean HgbA1c was 8.3 ± 1.2% and mean duration of diabetes was 4.8 ± 3.8 years. The study was approved by the NCH Institutional Review Board and informed consent was obtained from parent or legal guardian. Proper assent was obtained from all subjects.

Screening included a history, physical exam, Tanner staging, and fasting laboratory testing. Type 1 DM was defined by the American Diabetes Association Criteria plus a fasting C-peptide of less than 0.4 ng/mL, insulin monotherapy since diagnosis, and an absence of a history of oral hypoglycemic agents and acanthosis nigricans on exam. All subjects were nonsmokers by report.

All subjects were Tanner stage 2--4 in order to minimize the effects of starting or finishing puberty. In order to limit confounding effects on endothelial function, subjects with BP \> 95% tile, smoking, pregnancy, and uncorrected hypothyroidism were excluded. Subjects with microalbuminuria, overt nephropathy, or early renal failure (random urine microalbumin/creatinine \> 0.02 mg albumin/mg creatinine; serum creatinine \> 1.0 mg/dL) were also excluded.

2.2. Protocol {#sec2.2}
-------------

Subjects were admitted to the Clinical Research Center of the Wexner Medical Center at the Ohio State University at 0730 after having fasted from 2200 the night before. Subjects were instructed to take their usual basal insulin the night before or to remain on their usual basal insulin infusion rates if using continuous subcutaneous insulin. Subjects withheld their morning insulin bolus until breakfast was given after the study completion. Endothelial testing was then conducted as described below. A 20-minute rest period was held before endothelial-independent vasodilation assessed using sublingual 0.3 mg of glycerol trinitrate. A blood sample was then collected for measurement of fasting glucose and ECFCs. Eleven patients then participated in an insulin clamp study to assess the effects of glucose normalization and hyperglycemia. Results on this study have been previously reported \[[@B16]\]. Subjects were then placed on a continuous 24-hour glucose monitor (Medtronic Guardian, Fridley MN) for 3 days after which the monitor was returned and the data was downloaded using the Medtronic Carelink website to determine the mean glucose level and standard deviation.

2.3. Assessment of Endothelial and Nonendothelial Vasodilation {#sec2.3}
--------------------------------------------------------------

Forearm Blood Flow (FBF) was measured using strain gauge venous occlusion plethysmography, as previously described by Higashi and Yoshizumi \[[@B19]\], using a Hokanson EC6 plethysmograph (DE Hokanson Inc, Bellevue, WA) in the dominant arm. An indium-in-silastic strain gauge was attached to the widest portion of the forearm and connected to a plethysmography device. Sphygomanometric cuffs were placed on the arm at the wrist and on the upper arm. The wrist cuff was inflated to 200 mmHg to occlude blood flow to the hand for the duration of the study. During FBF measurement the upper arm cuff was inflated to 40 mmHg for 10 out of 15 seconds to occlude venous return but not arterial inflow. Each subject had two minutes of baseline flow recorded and then the upper arm cuff was inflated to 200 mmHg pressure for five minutes to occlude arterial flow to the arm. It was then released to create a sudden shear stress. FBF was again measured for the next minute. The FBF outflow signal was transmitted to a recorder (Powerlab 8, ADInstruments, Colorado Springs, CO) and FBF was expressed as mL per minute per 100 mL of forearm tissue volume. Forearm vascular resistance (FVR) was calculated by dividing mean arterial pressure (measured by automated sphygmomanometer) by FBF. All studies were scored by a single experienced investigator (RPH).

FBF was measured for 1 minute before and 5 minutes after glycerol trinitrate. The highest percent increase in 1 min postnitrate FBF or largest percent fall in FVR were used to assess endothelial-independent vasodilation.

2.4. Laboratory Measurements {#sec2.4}
----------------------------

Hemoglobin A1c levels were taken from the Pediatric Diabetes Clinic at Nationwide Children\'s. Measurements in the clinic are done using point of care testing on the DCA 2000 (Leverkusen, Germany).

ECFCs were measured using polychromatic flow cytometry methods. A 50 *μ*L volume anticoagulated peripheral blood was incubated with 50 *μ*L 3% BSA in PBS (without Ca++ and Mg++) at room temperature for 30 min. In dark, fluorescence labeled antibodies (2.5 *μ*L of each), PE-AC133, FITC-CD34, and PECy5-CD45, were added and incubated for 30 min at room temperature. FACS lysis buffer (450 *μ*L) was then added and incubated for 30 min at room temperature in dark. Samples were then analyzed on a FACS Calibur flow cytometer, where total counts are \>400,000 cells. Intra-assay variability from \~100 *μ*L whole blood was \<5%.

2.5. Statistical Analysis {#sec2.5}
-------------------------

HbA1cAUC was calculated using the trapezoidal rule. Pearson regression analysis was used to assess the relationship between vascular, ECFC\'s, and inflammatory and oxidative markers and the various measures of glucose control. *t*-tests were used for group comparisons. Data was log normalized, as needed. Analysis was performed using Systat 11 (SAS, Systat Software Inc, Chicago, IL). Results are shown as mean ± SD.

3. Results {#sec3}
==========

3.1. Vascular Measures {#sec3.1}
----------------------

Mean postocclusion FBF for the group was 19.2 ± 5.7 mL/dL min. Postocclusion FBF decreased as age increased (*r* = −0.55, *P* = 0.023) and as glucose control worsened as indicated by a negative relationship with the hemoglobin A1c at the time of study (*r* = −0.53, *P* = 0.030, [Figure 1](#fig1){ref-type="fig"}). The diminished postocclusive FBF was due to impaired vasodilation since postocclusive FVR increased as single hemoglobin A1c increased (*r* = 0.52, *P* = 0.031). Postocclusive FBF was not related to fasting glucose, 3 day mean glucose, or HbA1cAUC.

Mean postocclusive FVR was 4.9 ± 2.0 mmHg dL min/mL. Postocclusive FVR was positively related to log 3 day mean glucose (*r* = 0.55, *P* = 0.027[Figure 2](#fig2){ref-type="fig"}) and tended to be positively related to fasting glucose (*r* = 0.44, *P* = 0.098) but not to glucose standard deviation. Stepwise multiple regression including hemoglobin A1c, fasting, and log 3 day mean glucose revealed that only the log 3 day mean glucose significantly predicted postocclusion FVR. The ratio of post to preocclusive FBF was not related to any measure of glucose control while the percent change in FVR from preocclusion to postocclusion tended to worsen as fasting glucose increased (*r* = 0.46, *P* = 0.088).

Postocclusive FBF decreased as age increased (*r* = −0.55, *P* = 0.023) but was not related to BMI. None of the postocclusive FVR measures were significantly related to age or BMI. Neither postocclusive FBF nor postocclusive FVR was related to endothelial-independent vasodilation. Log absolute ECFC and percent ECFC were not significantly related to any glycemic measures, age, or BMI.

Median hemoglobin A1c for the 17 T1D subjects was 8.3%. To confirm the relationships of endothelial function to glycemic control, subjects were divided into two groups with hemoglobin A1c levels above and below the median. [Table 1](#tab1){ref-type="table"} shows age, duration of diabetes, BMI, blood pressure, and pre- and postocclusion FBF and FVR values for the two groups. Age, duration of diabetes, BMI, and blood pressure did not differ between the two groups. Both pre- and postocclusion FVR were increased in subjects with poorly controlled compared to well-controlled T1D. The results were confirmed by the FBF results where postocclusion FBF tended to be lower in poorly controlled T1D compared to well-controlled T1D (*P* = 0.084). ECFC\'s and maximal vasodilation in response to sublingual nitroglycerin T1D did not differ between poorly and well-controlled T1D subjects.

4. Discussion {#sec4}
=============

The results clearly demonstrate that in adolescent T1D poor intermediate-term glucose control impairs endothelial function since postocclusive FBF decreased and postocclusive FVR increased as hemoglobin A1c increased, indicating impaired maximal sheer stress and nitric oxide-induced vasodilation. This was confirmed by the increased postocclusive FVR and trend toward decreased FBF in poorly controlled T1D compared to well-controlled subjects.

Multiple methods have been used to assess endothelial function in the normal population and in adolescents with T1D \[[@B1]--[@B6]\]. These methods generally assess the change in either brachial artery diameter as indicated by ultrasound or the change in FBF or FVR as measured by venous occlusion plethysmography following upper arm vascular occlusion. While it is clear that this reactive hyperemic response is mediated by endothelial nitric oxide release \[[@B19]\], it is less clear which method is best to assess endothelial function in T1D. Furthermore, data from our laboratory indicates that acute hyperglycemia markedly increases preocclusion FBF and decreases preocclusion FVR which creates a ceiling and a floor effect, respectively, for assessing postocclusion changes in FBF and FVR \[[@B16]\]. Studies of young adult patients with T1D have demonstrated decreased basal limb blood flow in the leg \[[@B20]\] while studies in long standing T1D without complications have demonstrated increased limb blood flow in the arm \[[@B21]\]. Babar et al. found larger brachial artery baseline diameters in prepubertal subjects with T1D compared to control subjects \[[@B6]\]. From this data, it is clear that different plasma glucose levels may lead to alterations in basal (preocclusion) blood flow and brachial artery diameter that may potentially alter change measurements in FBF or brachial artery diameter, as indicators of endothelial function.

Recently, Nadeau et al. \[[@B4]\] have simply reported decreased postocclusive FBF in adolescents with T1D without assessing change scores. The diminished postocclusive FBF is likely an indicator of impaired, maximal endothelially induced vasodilation in adolescents with T1D. The data in the current study expand this finding by indicating that maximal postocclusive vasodilation decreases as intermediate- and short-term glucose control worsen as indicated by lower FBF and higher FVR with increasing hemoglobin A1c. The short-term nature of this effect was demonstrated by the fact that postocclusive FVR increased as 3 day average glucose increased. This decreased ability to increase blood flow in response to shear stress with poor glucose control may play a significant role in the development of cardiovascular disease in T1D. Endothelial dysfunction is, also, thought to play a significant role in the diabetic microvascular complications as well \[[@B13], [@B14], [@B24], [@B25]\].

In our study, intermediate-term and short-term glucose control (single hemoglobin A1c and 3 day mean glucose) were clearly associated with impaired endothelial function. This is the opposite of the findings of Babar et al. who found better endothelial function in T1D prepubertal subjects with poor glucose control \[[@B6]\]. They had no explanation for this finding. In older adolescents with less than 5 years duration, Ce et al. found that brachial artery flow mediated dilation significantly negatively correlated with mean hemoglobin A1c levels between 12 and 24 months before the measurement but not mean hemoglobin A1c levels between 0 and 12 months before the measurement \[[@B26]\]. They did not find this relationship in subjects with more than 5 years duration. They suggested that this relationship was an evidence of a metabolic memory affect. Our data is somewhat different in that we found a direct relationship with current hemoglobin A1c and no relationship to long-term glycemic control as indicated by HbA1cAUC. When only patients under 5 years duration were studied the relationships between FBF and single hemoglobin A1c and between FVR and log 3 day mean glucose remained significant (data not shown). Too few subjects had duration of more than 5 years to adequately assess whether there were duration related differences in these relationships but multilinear regression analysis did not reveal significant duration by hemoglobin A1c interactions. The reason that recent hemoglobin A1c had an effect in our study, and not theirs, is not immediately apparent. Possible explanations would include the younger subjects in the current study and different methods of assessing endothelial function. The importance of the effect of poor glycemic control is emphasized when postocclusion FBF and FVR from the T1D subjects are compared to that of results from healthy, pubertal control subjects from a previous study (FBF: 22.5 ± 4.5 mL/dL min; FVR: 4.1 ± 1.5 mmHg dL min/mL) \[[@B27]\]. Postocclusion FBF was significantly lower and FVR significantly increased in the subjects with hemoglobin A1c above the median.

Glucose variability was not significantly related to either postocclusive FBF or FVR. This finding was somewhat surprising since in vitro \[[@B17]\] and in vivo \[[@B18]\] studies have indicated that oscillating glucose leads to impaired endothelial function. These results, however, confirm results from Pena et al. which found no relationship between endothelial function, measured using brachial artery, flow-mediated vasodilation, and glucose variability from the continuous glucose monitor \[[@B5]\]. Interestingly, they did find a negative effect of hypoglycemia on endothelial function. We did not assess this relationship. Long-term glucose control was not significantly related to measures of endothelial function.

We found no relationships between ECFC\'s and glucose control. ECFC% was increased in our subjects compared to age-matched control subjects from a previous study (T1D, 0.115 ± 0.074 versus controls, 0.022 ± 0.017%, mean ± SD, *P* = 0.016) confirming previous findings by Dimeglio et al. \[[@B12]\]. They believed that the increased ECFCs in T1D were due to an ongoing response to endothelial injury; thus, it would be expected that ECFC counts would increase as endothelial function deteriorates. However, neither Dimeglio et al. nor we found a significant relationship between ECFCs and endothelial function \[[@B12]\]. They did find a negative relationship between CPCs, which we did not assess, and endothelial function. Hortenhuber et al. \[[@B28]\] found no difference in what they called circulating progenitor cells (CD 34+ CD133+) between control and type 1 diabetic subjects and lower endothelial progenitor cells (CD34+ CD133+ CD309+) in type 1 diabetes adolescents. They also found that these latter cells decreased as hemoglobin A1c increased.

The main limitation of this study is the small number of subjects studied which decreases our ability to truly assess the interactions between immediate, short-term, intermediate-term, and long-term glucose control and endothelial function. This was particularly true regarding postocclusive FVR which was significantly related to log 3 day mean glucose and single hemoglobin A1c and tended to be related to fasting glucose since log average glucose was positively correlated with both hemoglobin A1c (*r* = 0.56, *P* = 0.025) and fasting glucose (*r* = 0.88, *P* \< 0.001) while the latter two were not related. The fact that postocclusive FBF was only related to single hemoglobin A1c supports our contention that intermediate glycemic control is most important.

5. Conclusions {#sec5}
==============

Our results demonstrate that short and intermediate-term, poor glucose control are associated with diminished endothelial function in pubertal T1D adolescents. Since impaired endothelial function is a precursor for future cardiovascular disease, these results emphasize the need to achieve good diabetes control in adolescents.
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###### 

Demographics, blood pressure, and pre-and postocclusion FBF and FVR in adolescents with type 1 diabetes according to glucose control.

                         A1c ≤ 8.3%      A1c \> 8.3%
  ---------------------- --------------- ----------------
  Age (years)            12.5 ± 1.6      13.8 ± 1.2
  Duration (years)       4.1 ± 2.5       5.4 ± 5.1
  BMI (kg/m^2^)          20.1 ± 4.0      20.4 ± 2.0
  SBP (mmHg)             106 ± 5         107 ± 7
  DBP (mmHg)             63 ± 10         60 ± 8
                                         
                         Preocclusion    
  FBF (mL/dL min)        3.4 ± 0.5       2.8 ± 1.1
  FVR (mmHg dL min/mL)   23.9 ± 4.4      31.4 ± 10.4^b^
                                         
                         Postocclusion   
  FBF (mL/dL min)        22.0 ± 4.8      16.5 ± 5.3^a^
  FVR (mmHg dL min/mL)   4.0 ± 1.1       6.0 ± 2.3^c^

^a^ *P* = 0.084 versus well-controlled, ^b^ *P* = 0.047 versus well-controlled, and ^c^ *P* = 0.015 versus well-controlled.
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